PMID: 16514382Mar 4, 2006Paper

Cost-effectiveness of colorectal cancer screening

Gastroentérologie Clinique Et Biologique
Denis HeresbachJean-François Bretagne

Abstract

Colorectal cancer (CRC) screening in France is based on a faecal occult blood test every two years in average risk subjects 50-74 years of age while other endoscopic or non-endoscopic screening methods are used in Europe and in the USA. Beside the reduced incidence of and mortality from CRC found in available studies, cost-effectiveness data need to be taken into account. Because of the delay between randomized controlled trials and clinical results, transitional probabilistic models of screening programs are useful for public health policy makers. The aim of the present review was to promote the implementation of cost-effectiveness studies, to provide a guide to analyze cost-effectiveness studies on CRC screening and, to propose a French cost effectiveness study comparing CRC screening strategies. Most of these trials were performed by US or UK authors and demonstrate that the incremental cost-effectiveness ratio varies between 5 000 and 15 000 US dollars/one year life gained, with wide variations: these results were highly dependent on the unit costs of the different devices as well as the predictive values of the screening tests. Although CRC screening programs have been implemented in several administrative districts of Fra...Continue Reading

References

Feb 1, 1979·Endoscopy·S GranqvistP Sundelin
May 1, 1979·Cancer·R R RickertJ M Frasca
Dec 1, 1978·Cancer·T J Eide, H Stalsberg
Nov 15, 1991·Annals of Internal Medicine·J L WagnerS Wadhwa
Jan 1, 1988·Diseases of the Colon and Rectum·J M ChurchI T Jones
Nov 1, 1987·Gastroenterology·S J StrykerR L MacCarty
Aug 15, 1986·International Journal of Cancer. Journal International Du Cancer·T J Eide
Aug 15, 1985·International Journal of Cancer. Journal International Du Cancer·J C ClarkJ G Simpson
Feb 1, 1982·Gastrointestinal Endoscopy·F J TedescoL R Mills
May 1, 1982·Endoscopy·C B WilliamsC I Bartram
Dec 1, 1995·Gastroenterology·D A Lieberman
Sep 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J SmithT Le Chevalier
Jan 1, 1994·International Journal of Technology Assessment in Health Care·T ShimboJ M Eisenberg
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Jan 1, 1997·International Journal of Colorectal Disease·G NuskoE G Hahn
Apr 16, 1998·Health Economics·D Gyrd-HansenO Kronborg
Apr 16, 1998·Health Economics·D K WhynesJ D Hardcastle
Jul 29, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Norum
Aug 13, 1999·The American Journal of Gastroenterology·A SonnenbergP Bauerfeind
Nov 24, 1999·European Journal of Gastroenterology & Hepatology·F Delcò, A Sonnenberg
Apr 6, 2000·Journal of the National Cancer Institute·F LoeveJ D Habbema
Aug 5, 2000·The American Journal of Gastroenterology·R M NessR Dittus
Oct 12, 2000·International Journal of Technology Assessment in Health Care·R K KhandkerW B Baine
Oct 18, 2000·Annals of Internal Medicine·A SonnenbergJ M Inadomi
Oct 18, 2000·JAMA : the Journal of the American Medical Association·A L FrazierK M Kuntz
Nov 30, 2000·The American Journal of Gastroenterology·J F HelmR S Sandler
Nov 30, 2000·The New England Journal of Medicine·J S MandelL M Schuman
Apr 12, 2001·The Medical Journal of Australia·T D BolinM G Korman
Sep 1, 2001·The New England Journal of Medicine·D A LiebermanUNKNOWN Veterans Affairs Cooperative Study Group 380
Sep 11, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E FrewD K Whynes
Nov 23, 2001·Health Care Management Science·R T Clemen, C J Lacke
Jan 5, 2002·The American Journal of Medicine·S VijanR A Hayward
Jan 10, 2002·Gastroenterology·Saud SuleimanAmnon Sonnenberg
Feb 13, 2002·Archives of Internal Medicine·Amnon Sonnenberg, Fabiola Delcò
Feb 28, 2002·The American Journal of Gastroenterology·Scott D RamseyRuth Etzioni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.